Levoleucovorin
Showing 26 - 50 of 653
Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)
Active, not recruiting
- Colorectal Cancer
- Metastatic Cancer
- FOLFOX regimen
- +7 more
-
New Brunswick, New Jersey
- +1 more
Jul 1, 2022
Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Cisplatin)
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- Pembrolizumab
- +7 more
-
Louisville, Kentucky
- +91 more
Mar 30, 2022
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)
Not yet recruiting
- Colorectal Cancer
- mFOLFOXIRI + Cadonilimab
- mFOLFOX6
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022
Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,
Not yet recruiting
- Advanced Cancer
- +16 more
- Fosifloxuridine Nafalbenamide
- +3 more
-
Birmingham, United Kingdom
- +3 more
Feb 1, 2023
Colorectal Cancer Trial in Vejle (Irinotecan 165 mg/m2 iv, Oxaliplatin 85 mg/m2 iv, Calcium folinate 200 mg/m2 iv)
Active, not recruiting
- Colorectal Cancer
- Irinotecan 165 mg/m2 iv
- +5 more
-
Vejle, DenmarkDepartment of Oncology, Vejle Hospital
Aug 16, 2022
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)
Recruiting
- Colorectal Cancer
- mFOLFOXIRI plus Bevacizumab
- mFOLFOX6 Plus Bevacizumab
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022
Advanced/Metastatic Colorectal Cancer Trial in Guangzhou (Dalpiciclib, Oxaliplatin injection, Calcium folinate)
Not yet recruiting
- Advanced/Metastatic Colorectal Cancer
- Dalpiciclib
- +3 more
-
Guangzhou, Guangdong, ChinaSixth Affiliated Hospital, Sun Yat-sen University
Jul 28, 2022
Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)
Active, not recruiting
- Metastatic Colorectal Cancer
- CMAB009
- +3 more
-
Beijing, Beijing, China
- +1 more
Oct 18, 2022
Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)
Withdrawn
- Colorectal Cancer
- Metastatic Cancer
- FOLFIRI regimen
- +7 more
-
Boulogne Billancourt, FranceHopital Ambroise Pare
Aug 26, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)
Not yet recruiting
- Unresectable Metastatic Colorectal Cancer
- ABBV-400
- +4 more
- (no location specified)
Oct 25, 2023
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,
Recruiting
- Metastatic Colorectal Cancer
- Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
- Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
-
Avignon, France
- +5 more
Aug 2, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Colorectal Cancer Trial in Harbin (AK119, AK112, Oxaliplatin)
Not yet recruiting
- Colorectal Cancer
- AK119
- +5 more
-
Harbin, ChinaCancer Hospital Affiliated to Harbin Medical University
May 5, 2023
Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine
Recruiting
- Neuroendocrine Tumors
- 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
- +4 more
-
Palo Alto, California
- +30 more
Dec 14, 2022
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Hepatocellular Carcinoma, Liver Transplantation Trial in Nanjing (Transarterial chemoinfusion (TAI) with mFOLFOX6 (oxaliplatin,
Recruiting
- Hepatocellular Carcinoma
- Liver Transplantation
- Transarterial chemoinfusion (TAI) with mFOLFOX6 (oxaliplatin, calcium folinate, and 5-FU)
-
Nanjing, Jiangsu, ChinaNanjing Drum tower hospital
Oct 28, 2021